Change of Helicobacter pylori prevalence in a decade among children undergoing endoscopy

Aytaç Yaman1, Zarife Kuloğlu1, Ahmet Kahveci2

  • 1Ankara University Faculy of Medicine, Pediatric Gastroenterology, Ankara, Turkey.

Insights

Helicobacter pylori (H. pylori) infection rates significantly decreased in children undergoing upper endoscopy in Ankara over a decade. This trend suggests a positive public health impact on pediatric H. pylori prevalence.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Public Health

Background:

  • Helicobacter pylori (H. pylori) infection is a significant cause of gastritis and peptic ulcers in children.
  • Understanding trends in H. pylori prevalence is crucial for assessing the effectiveness of control strategies and informing clinical practice.
  • Previous studies have indicated varying H. pylori prevalence rates globally, with a need for region-specific data, particularly in pediatric populations.

Purpose of the Study:

  • To investigate the temporal trend of H. pylori infection in pediatric patients over a ten-year period.
  • To analyze the association between H. pylori infection and the prevalence of gastritis and atrophy in children.
  • To provide updated data on pediatric H. pylori prevalence in Ankara, Turkey.

Main Methods:

  • Retrospective analysis of esophagogastroduodenoscopy (EGD) reports from pediatric patients.
  • Patients were divided into two groups based on EGD performance: 2002-2003 (Group I) and 2012-2013 (Group II).
  • Pathology reports were reviewed for H. pylori presence, gastritis, and atrophy; statistical analysis compared prevalence between groups.

Main Results:

  • A total of 380 children were included (131 in Group I, 249 in Group II).
  • H. pylori positivity significantly decreased from 48.1% in Group I to 23.1% in Group II (p < 0.001).
  • Both gastritis and atrophy were significantly more prevalent in Group I and associated with H. pylori infection (p < 0.001).

Conclusions:

  • H. pylori prevalence has significantly decreased in the pediatric population undergoing EGD in Ankara over the past decade.
  • The observed decline may reflect improved sanitation, public health interventions, or changes in diagnostic practices.
  • This study provides the most current data on pediatric H. pylori prevalence trends in Turkey, highlighting a positive public health development.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.5K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
654
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
344
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
905
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
976
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
4.1K